SYNTHESIS OF IMIDAZO[1,2-C]PYRAZOLO[4,3-E]PYRIMIDINES, PYRAZOLO[4,3-E]1,2,4-TRIAZOLO[1,5-C]PYRIMIDINES AND 1,2,4-TRIAZOLO[5,1-I]PURINES - NEW POTENT ADENOSINE-A(2)-RECEPTOR ANTAGONISTS

被引:80
作者
GATTA, F
DELGIUDICE, MR
BORIONI, A
BOREA, PA
DIONISOTTI, S
ONGINI, E
机构
[1] SCHERING PLOUGH SPA,RIC LAB,MILAN,ITALY
[2] UNIV FERRARA,IST FARMACOL,I-44100 FERRARA,ITALY
关键词
IMIDAZO[1,2-C]PYRAZOLO[4,3-E]PYRIMIDINES; PYRAZOLO[4,3-E]1,2,4-TRIAZOLO[1,5-C]PYRIMIDINES; 1,2,4-TRIAZOLO[5,1-I]PURINES; ADENOSINE-A(2)-RECEPTOR ANTAGONISTS;
D O I
10.1016/0223-5234(93)90087-U
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A number of 2- or 4-fluorobenzylderivatives of imidazo[1,2-c]pyrazolo[4,3-e]pyrimidine, pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine and 1,2,4-triazolo[5,1-i] purine have been synthesized. The interaction with the adenosine A2 and A1 receptors was evaluated using selected biological assays . The highest degree of activity was displayed by the 5-amino-2-(2-furyl)-7-(or 8-)-fluorobenzyl-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine 13e, f and 18e, f and -3-fluorobenzyl-1-2-4-triazolo[5,1-i] purines 19e, f. The compound 18f was found to be the most potent A2 antagonist in our series with a selectivity similar to that of the reference compound CGS 15943, but with 75-fold more activity in the platelet aggregation model.
引用
收藏
页码:569 / 576
页数:8
相关论文
共 20 条
[1]  
BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
[2]  
BROWN BL, 1972, ADV CYCL NUCL RES<D>, V2, P25
[3]   ADENOSINE RECEPTORS IN BRAIN MEMBRANES - BINDING OF N6-CYCLOHEXYL[H-3]ADENOSINE AND 1,3-DIETHYL-8-[H-3]PHENYLXANTHINE [J].
BRUNS, RF ;
DALY, JW ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09) :5547-5551
[4]   NON-XANTHINE HETEROCYCLES - ACTIVITY AS ANTAGONISTS OF A1-ADENOSINE AND A2-ADENOSINE RECEPTORS [J].
DALY, JW ;
HONG, O ;
PADGETT, WL ;
SHAMIM, MT ;
JACOBSON, KA ;
UKENA, D .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (04) :655-664
[5]  
DIONISOTTI S, 1992, N-S ARCH PHARMACOL, V346, P673
[6]   STRUCTURE ACTIVITY PROFILE OF A SERIES OF NOVEL TRIAZOLOQUINAZOLINE ADENOSINE ANTAGONISTS [J].
FRANCIS, JE ;
CASH, WD ;
PSYCHOYOS, S ;
GHAI, G ;
WENK, P ;
FRIEDMANN, RC ;
ATKINS, C ;
WARREN, V ;
FURNESS, P ;
HYUN, JL ;
STONE, GA ;
DESAI, M ;
WILLIAMS, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (05) :1014-1020
[7]   SYNTHESIS OF 7,8-DIHYDRO-6H-PYRAZOLO[3,4-B]QUINOLIN-5-ONES AND RELATED DERIVATIVES [J].
GATTA, F ;
POMPONI, M ;
MARTA, M .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1991, 28 (05) :1301-1307
[8]  
GHAI G, 1987, J PHARMACOL EXP THER, V242, P784
[9]  
Haslam R. J., 1981, PURINERGIC RECEPTORS, P223
[10]   REARRANGEMENTS IN HETEROCYCLIC SYNTHESIS - A NOVEL TRANSLOCATION OF AN (N-AMINO-N-METHYLAMINO)METHYLENE GROUP FROM A HETEROCYCLIC N-AMINO-N-METHYLFORMAMIDINE SIDE-CHAIN TO THE VINYLOGOUS NITRILE FUNCTION [J].
HOSMANE, RS ;
LIM, BB ;
BURNETT, FN .
JOURNAL OF ORGANIC CHEMISTRY, 1988, 53 (02) :382-386